Cargando…
Evaluating the impact of mobility in COVID-19 incidence and mortality: A case study from four states of Mexico
INTRODUCTION: The COVID-19 pandemic in Mexico began at the end of February 2020. An essential component of control strategies was to reduce mobility. We aimed to evaluate the impact of mobility on COVID- incidence and mortality rates during the initial months of the pandemic in selected states. METH...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387383/ https://www.ncbi.nlm.nih.gov/pubmed/35991046 http://dx.doi.org/10.3389/fpubh.2022.877800 |
_version_ | 1784770005722726400 |
---|---|
author | Méndez-Lizárraga, César Arturo Castañeda-Cediel, MLucía Delgado-Sánchez, Guadalupe Ferreira-Guerrero, Edith Elizabeth Ferreyra-Reyes, Leticia Canizales-Quintero, Sergio Mongua-Rodríguez, Norma Tellez-Vázquez, Norma Jiménez-Corona, María Eugenia Bradford Vosburg, Kathryn Bello-Chavolla, Omar Y. García-García, Lourdes |
author_facet | Méndez-Lizárraga, César Arturo Castañeda-Cediel, MLucía Delgado-Sánchez, Guadalupe Ferreira-Guerrero, Edith Elizabeth Ferreyra-Reyes, Leticia Canizales-Quintero, Sergio Mongua-Rodríguez, Norma Tellez-Vázquez, Norma Jiménez-Corona, María Eugenia Bradford Vosburg, Kathryn Bello-Chavolla, Omar Y. García-García, Lourdes |
author_sort | Méndez-Lizárraga, César Arturo |
collection | PubMed |
description | INTRODUCTION: The COVID-19 pandemic in Mexico began at the end of February 2020. An essential component of control strategies was to reduce mobility. We aimed to evaluate the impact of mobility on COVID- incidence and mortality rates during the initial months of the pandemic in selected states. METHODS: COVID-19 incidence data were obtained from the Open Data Epidemiology Resource provided by the Mexican government. Mobility data was obtained from the Observatory for COVID-19 in the Americas of the University of Miami. We selected four states according to their compliance with non-pharmaceutical interventions and mobility index. We constructed time series and analyzed change-points for mobility, incidence, and mortality rates. We correlated mobility with incidence and mortality rates for each time interval. Using mixed-effects Poisson models, we evaluated the impact of reductions in mobility on incidence and mortality rates, adjusting all models for medical services and the percentage of the population living in poverty. RESULTS: After the initial decline in mobility experienced in early April, a sustained increase in mobility followed during the rest of the country-wide suspension of non-essential activities and the return to other activities throughout mid-April and May. We identified that a 1% increase in mobility yielded a 5.2 and a 2.9% increase in the risk of COVID-19 incidence and mortality, respectively. Mobility was estimated to contribute 8.5 and 3.8% to the variability in incidence and mortality, respectively. In fully adjusted models, the contribution of mobility to positive COVID-19 incidence and mortality was sustained. When assessing the impact of mobility in each state compared to the state of Baja California, increased mobility conferred an increased risk of incident positive COVID-19 cases in Mexico City, Jalisco, and Nuevo León. However, for COVID-19 mortality, a differential impact of mobility was only observed with Jalisco and Nuevo León compared to Baja California. CONCLUSION: Mobility had heterogeneous impacts on COVID-19 rates in different regions of Mexico, indicating that sociodemographic characteristics and regional-level pandemic dynamics modified the impact of reductions in mobility during the COVID-19 pandemic. The implementation of non-pharmaceutical interventions should be regionalized based on local epidemiology for timely response against future pandemics. |
format | Online Article Text |
id | pubmed-9387383 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93873832022-08-19 Evaluating the impact of mobility in COVID-19 incidence and mortality: A case study from four states of Mexico Méndez-Lizárraga, César Arturo Castañeda-Cediel, MLucía Delgado-Sánchez, Guadalupe Ferreira-Guerrero, Edith Elizabeth Ferreyra-Reyes, Leticia Canizales-Quintero, Sergio Mongua-Rodríguez, Norma Tellez-Vázquez, Norma Jiménez-Corona, María Eugenia Bradford Vosburg, Kathryn Bello-Chavolla, Omar Y. García-García, Lourdes Front Public Health Public Health INTRODUCTION: The COVID-19 pandemic in Mexico began at the end of February 2020. An essential component of control strategies was to reduce mobility. We aimed to evaluate the impact of mobility on COVID- incidence and mortality rates during the initial months of the pandemic in selected states. METHODS: COVID-19 incidence data were obtained from the Open Data Epidemiology Resource provided by the Mexican government. Mobility data was obtained from the Observatory for COVID-19 in the Americas of the University of Miami. We selected four states according to their compliance with non-pharmaceutical interventions and mobility index. We constructed time series and analyzed change-points for mobility, incidence, and mortality rates. We correlated mobility with incidence and mortality rates for each time interval. Using mixed-effects Poisson models, we evaluated the impact of reductions in mobility on incidence and mortality rates, adjusting all models for medical services and the percentage of the population living in poverty. RESULTS: After the initial decline in mobility experienced in early April, a sustained increase in mobility followed during the rest of the country-wide suspension of non-essential activities and the return to other activities throughout mid-April and May. We identified that a 1% increase in mobility yielded a 5.2 and a 2.9% increase in the risk of COVID-19 incidence and mortality, respectively. Mobility was estimated to contribute 8.5 and 3.8% to the variability in incidence and mortality, respectively. In fully adjusted models, the contribution of mobility to positive COVID-19 incidence and mortality was sustained. When assessing the impact of mobility in each state compared to the state of Baja California, increased mobility conferred an increased risk of incident positive COVID-19 cases in Mexico City, Jalisco, and Nuevo León. However, for COVID-19 mortality, a differential impact of mobility was only observed with Jalisco and Nuevo León compared to Baja California. CONCLUSION: Mobility had heterogeneous impacts on COVID-19 rates in different regions of Mexico, indicating that sociodemographic characteristics and regional-level pandemic dynamics modified the impact of reductions in mobility during the COVID-19 pandemic. The implementation of non-pharmaceutical interventions should be regionalized based on local epidemiology for timely response against future pandemics. Frontiers Media S.A. 2022-08-04 /pmc/articles/PMC9387383/ /pubmed/35991046 http://dx.doi.org/10.3389/fpubh.2022.877800 Text en Copyright © 2022 Méndez-Lizárraga, Castañeda-Cediel, Delgado-Sánchez, Ferreira-Guerrero, Ferreyra-Reyes, Canizales-Quintero, Mongua-Rodríguez, Tellez-Vázquez, Jiménez-Corona, Bradford Vosburg, Bello-Chavolla and García-García. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Méndez-Lizárraga, César Arturo Castañeda-Cediel, MLucía Delgado-Sánchez, Guadalupe Ferreira-Guerrero, Edith Elizabeth Ferreyra-Reyes, Leticia Canizales-Quintero, Sergio Mongua-Rodríguez, Norma Tellez-Vázquez, Norma Jiménez-Corona, María Eugenia Bradford Vosburg, Kathryn Bello-Chavolla, Omar Y. García-García, Lourdes Evaluating the impact of mobility in COVID-19 incidence and mortality: A case study from four states of Mexico |
title | Evaluating the impact of mobility in COVID-19 incidence and mortality: A case study from four states of Mexico |
title_full | Evaluating the impact of mobility in COVID-19 incidence and mortality: A case study from four states of Mexico |
title_fullStr | Evaluating the impact of mobility in COVID-19 incidence and mortality: A case study from four states of Mexico |
title_full_unstemmed | Evaluating the impact of mobility in COVID-19 incidence and mortality: A case study from four states of Mexico |
title_short | Evaluating the impact of mobility in COVID-19 incidence and mortality: A case study from four states of Mexico |
title_sort | evaluating the impact of mobility in covid-19 incidence and mortality: a case study from four states of mexico |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387383/ https://www.ncbi.nlm.nih.gov/pubmed/35991046 http://dx.doi.org/10.3389/fpubh.2022.877800 |
work_keys_str_mv | AT mendezlizarragacesararturo evaluatingtheimpactofmobilityincovid19incidenceandmortalityacasestudyfromfourstatesofmexico AT castanedacedielmlucia evaluatingtheimpactofmobilityincovid19incidenceandmortalityacasestudyfromfourstatesofmexico AT delgadosanchezguadalupe evaluatingtheimpactofmobilityincovid19incidenceandmortalityacasestudyfromfourstatesofmexico AT ferreiraguerreroedithelizabeth evaluatingtheimpactofmobilityincovid19incidenceandmortalityacasestudyfromfourstatesofmexico AT ferreyrareyesleticia evaluatingtheimpactofmobilityincovid19incidenceandmortalityacasestudyfromfourstatesofmexico AT canizalesquinterosergio evaluatingtheimpactofmobilityincovid19incidenceandmortalityacasestudyfromfourstatesofmexico AT monguarodrigueznorma evaluatingtheimpactofmobilityincovid19incidenceandmortalityacasestudyfromfourstatesofmexico AT tellezvazqueznorma evaluatingtheimpactofmobilityincovid19incidenceandmortalityacasestudyfromfourstatesofmexico AT jimenezcoronamariaeugenia evaluatingtheimpactofmobilityincovid19incidenceandmortalityacasestudyfromfourstatesofmexico AT bradfordvosburgkathryn evaluatingtheimpactofmobilityincovid19incidenceandmortalityacasestudyfromfourstatesofmexico AT bellochavollaomary evaluatingtheimpactofmobilityincovid19incidenceandmortalityacasestudyfromfourstatesofmexico AT garciagarcialourdes evaluatingtheimpactofmobilityincovid19incidenceandmortalityacasestudyfromfourstatesofmexico |